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Abstract
T cell development occurs in the thymus and is critically dependent on productive TCRb rearrangement and pre-TCR
expression in DN3 cells. The requirement for pre-TCR expression results in the arrest of thymocytes at the DN3 stage (b
checkpoint), which is uniquely permissive for V-DJb recombination; only cells expressing pre-TCR survive and develop
beyond the DN3 stage. In addition, the requirement for TCRb rearrangement and pre-TCR expression enforces suppression
of TCRb rearrangement on a second allele, allelic exclusion, thus ensuring that each T cell expresses only a single TCRb
product. However, it is not known whether pre-TCR expression is essential for allelic exclusion or alternatively if allelic
exclusion is enforced by developmental changes that can occur in the absence of pre-TCR. We asked if thymocytes that
were differentiated without pre-TCR expression, and therefore without pause at the b checkpoint, would suppress all V-DJb
rearrangement. We previously reported that premature CD28 signaling in murine CD4
2CD8
2 (DN) thymocytes supports
differentiation of CD4
+CD8
+ (DP) cells in the absence of pre-TCR expression. The present study uses this model to define
requirements for TCRb rearrangement and allelic exclusion. We demonstrate that if cells exit the DN3 developmental stage
before TCRb rearrangement occurs, V-DJb rearrangement never occurs, even in DP cells that are permissive for D-Jb and
TCRa rearrangement. These results demonstrate that pre-TCR expression is not essential for thymic differentiation to DP
cells or for V-DJb suppression. However, the requirement for pre-TCR signals and the exclusion of alternative stimuli such as
CD28 enforce a developmental ‘‘pause’’ in early DN3 cells that is essential for productive TCRb rearrangement to occur.
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Introduction
In order to generate mature ab T cells, developing thymocytes
must negotiate developmental checkpoints that depend upon the
rearrangement of TCR a and b genes. During conventional
thymic development DN3 cells that express a surface pre-TCR
consisting of a productively rearranged TCRb chain, an invariant
pre-TCRa chain, and CD3 components, successfully negotiate the
‘‘b checkpoint’’ and differentiate. Although circumstances have
been described that allow the generation of DN4 cells in the
absence of expressed TCRb (and pre-TCR) or TCRcd [1,2]
successful differentiation of the vast majority of DN4 thymocytes
in adult mice requires pre-TCR signals to allow rescue from
apoptosis, extensive proliferation, and development to CD4
+CD8
+
DP thymocytes [3,4]. In addition pre-TCR signals also inhibit V-
DJb rearrangement on a second chromosome (allelic exclusion or
b suppression) thereby assuring that each developing T cell
expresses only a single TCRb chain [5,6]. We have studied TCRb
rearrangement and allelic exclusion and asked if these events
absolutely require pre-TCR expression or alternatively if they are
regulated by developmental changes that can occur in the absence
of pre-TCR expression.
We previously reported that expressing CD28 and B7-2 as
transgenes (CD28/B7) beginning in early DN3 cells replaced pre-
TCR function at the b checkpoint. Expression of CD28/B7
transgenes in normal mice allowed the development of substantial
numbers of DP cells that lack TCRb expression. Further, when
CD28/B7 transgenes were expressed in pre-TCR-deficient
CD3eKO or RAG2KO mice, DP cells were also efficiently
generated in the complete absence of pre-TCR expression [7]. In
the studies reported here, we have used this murine model to
examine developmentally induced changes in early DN thymo-
cytes that regulate TCRb rearrangement and allelic exclusion
under conditions in which differentiation is not linked to pre-TCR
expression. We asked whether thymocytes that are driven to
differentiate without pause at the b checkpoint would ever
undergo V-DJb rearrangement.
This current study demonstrates that, in contrast to D–Jb
rearrangement, the opportunity for V-DJb rearrangement occurs
in a very limited developmental window that is restricted to early
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20639thymic DN3 cells [8,9]. Pre-TCR expression is not required to
enforce b suppression, but rather inhibition of V-DJb rearrange-
ment is enforced by at least two distinct and developmentally-
regulated mechanisms that do not require pre-TCR expression:
inhibition of RAG2 expression and, as measured by H3K4 tri-
methylation and germline transcription, selective suppression of
accessibility of the 59 Vb region. These findings support a novel
model of pre-TCR function, namely, that the requirement for pre-
TCR signaling enforces an essential ‘‘pause’’ in development at
the early thymic DN3 stage that is uniquely permissive for TCRb
rearrangement and subsequent TCRab expression.
Materials and Methods
Animals
C57BL/6 (B6) mice were obtained from Frederick Cancer
Research Facility. B7-2 transgenic Line 7 (B7), CD28WT
transgenic (CD28), CD3eKO, and RAG2KO mice were gener-
ated as previously described [7]. The B7-2 Line 7 transgenic mice
express murine B7-2 under the control of the H-2Kb promoter
and the Ig m chain enhancer [10] and the CD28WT transgenic
mice express murine CD28 under the control of the human CD2
promoter/enhancer [11]. RAG2-GFP reporter mice were gener-
ously provided by M. Nussenzweig (Rockefeller University, New
York City, NY). The indicated CD28, B7, and RAG2-GFP
transgenic mice were bred onto the B6, CD3eKO or RAG2KO
backgrounds, as indicated at Bioqual (Rockville, MD). All mice
were used at 2–4 months of age. All animal experiments were
approved by both the Bioqual and the National Cancer Institute
Animal Care and Use Committees and assigned protocol numbers
09-3447-79 (Bioqual) and EIB 079 (National Cancer Institute).
Antibodies
CD4-PE, CD4-biotin, CD8-biotin, TCRb-FITC (H57), CD44-
APC, CD25-PE (PC61), B220-biotin, TCRcd-biotin(GL3), Mac-
1-biotin, NK1.1-biotin, GR-1-biotin, and CD28-biotin antibodies
(mAbs) were purchased from BD Biosciences (San Diego, CA).
CD8-Alexa Fluor 647 (Al647) mAb was purchased from Invitro-
gen (Carlsbad CA). Steptavidin-PE-Cy5 (Av-PE-Cy5) and the
BrdU-FITC staining kit were purchased from BD Biosciences.
Streptavidin-Alexa Fluor 594 (Av-Al594) was purchased from
Molecular Probes (Eugene, OR). FccII/FccIII (24G2)- and B7-2-
specific (GL1) mAbs were previously described [7].
Cell staining and purification
Single cell suspensions were prepared and stained as previously
described [7] and analyzed by FACScan or FACScaliber (Becton
Dickinson, San Jose, CA) using either FlowJo (Tree Star, Inc.,
Ashland, OR) or CellQuest (BD Biosciences) software. To identify
DN thymocyte subsets, lineage-positive cells were incubated with
biotin-conjugated mAbs specific for CD4, CD8, H57, TCRcd,
B220, Mac-1, NK1.1, and GR-1 followed by staining with anti-
CD25 and anti-CD44 mAb. After extensive washing, Av-Al594
was added. DN cells were identified by gating on lineage-negative
cells and forward scatter (FSC).
For some experiments DN cells were enriched by simultaneous
CD4- and CD8-specific magnetic bead depletion (Milteny Biotec,
Auburn CA), resulting in .94% pure DN cells that contained
,1% DP cells. In select experiments DN2/3, DN4 cells, or DP
cells were purified by flow cytometry (.98% pure).
In vivo incorporation of BrdU
Mice were injected intraperitoneally two times with 1 mg BrdU
at 4 and 2 hours prior to sacrifice. Thymi were harvested and
surface stained as described above, followed by fixation,
permeabilization and intracellular staining with anti-BrdU-FITC
according to the manufacturer’s instructions (BD Biosciences).
Detection of TCRb and TCRa rearrangement
DN2/3, DN4, and DP thymocytes were purified by flow
cytometry; DNA was prepared using the Wizard Genomic DNA
Purification kit (Promega, Madison,WI) and serial dilutions of
DNA were assayed by semi-quantitative PCRs specific for Db2-
Jb2, Vb5-Jb2a n dV b8-Jb2 and Vb14-Jb2 rearrangements. DNA
was also assayed by semi-quantitative PCRs specific for Va2-
Ja50.1, Va2-Ja26, Va10-Ja50.1, or Va10-Ja26 rearrangements,
and with IgM-specific primers as a loading control. Primers used
are listed in Table S1. All PCRs were modified from previously
published protocols [12–14], used Amplitaq Gold (Applied
Biosystems, Foster City, CA), and were performed at the
following conditions: 10 min at 95uC, (45 s at 94uC, 90 s at
65uC (TCRb) or 50 s at 60uC (TCRa) , 150 s at 72uC)632
cycles, 10 min at 72uC.
Real-time PCR for RAG2 expression
DN2/3, DN4 or DP cells were purified by flow cytometry, and
total RNA was isolated using the RNeasy kit (Qiagen, Valencia
CA) with on-column DNase treatment. 400 ng RNA was
converted to cDNA using the SuperScriptHIII First-Strand
Synthesis System (Invitrogen, Carlsbad CA). SYBRH Green-based
real-time PCR was performed using buffers and primers specific
for RAG2 and, as a loading control, b-actin. All primers and
buffers were purchased from SABiosciences (Frederick, MD). All
real-time PCR assays were performed using replicate samples and
two different concentrations of DNA. RT
2 samples were included
as a negative control in all experiments.
Chromatin Immunoprecipitation (ChIP) analysis
RAG2KO cells (whole thymus) or enriched DN cells from
CD28/B7/RAG2KO mice were subjected to ChIP as previously
described [15] with minor modifications. Immunoprecipitating
antibodies were obtained from Millipore (Billerica, MA). Formal-
dehyde crosslinked and sonicated chromatin from 5610
6 cells was
pre-cleared with 5 mg non-specific IgG and immunoprecipitated
with 5 mg anti-H3K4Me3 mAb or an equal amount of non-
specific IgG. The precipitated DNA was purified, quantified
fluorometrically and analyzed by real-time PCR to amplify the
indicated TCRb regions. Primers are listed in Supplementary
Table S2.
Detection of TCRb germline transcription
Total RNA was prepared from enriched DN cells using the
RNeasy kit (Qiagen). RNA was converted to cDNA using the
SuperScriptHIII First-Strand Synthesis System (Invitrogen) and
assayed using semiquantitative PCRs and primers specific for
germline transcription of Db(1 and 2), Jb(1 and 2) or Vb(4.1, 5.1,
8.2, and 14.1), and for b-actin as a loading control. Primers are
listed in Table S3. All PCRs were modified from previously
established protocols [16,17], use Amplitaq Gold (AppliedBiosys-
tems, Foster City, CA), and were performed at the following
conditions: for Db and Jb: 10 min at 95uC, (20 s at 94uC, 30 s at
65uC, 60 s at 72uC)635 cycles, 10 min at 72uC; for Vb4.1 and
Vbb14.1: 10 min at 95uC, (45 s at 94uC, 45 s at 65uC, 60 s at
72uC)635 cycles, 10 min at 72uC; and for Vb5.1 and Vb5.1–8.2:
10 min at 95uC, (20 s at 94uC, 20 s at 54uC, 60 s at 72uC)635
cycles, 10 min at 72uC. RT-minus samples were included as a
negative control.
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RAG2KO mice
As described previously [18], RAG2KO mice were injected IP
with either PBS or 200 mg of CD3e-specific mAb (2C11). Thymi
were harvested at 3–6 days post-injection and analyzed by flow
cytometry for CD4 and CD8 subsets. Enriched DN cells were
prepared from individual mice by simultaneous CD4- and CD8-
specific magnetic bead depletion.
Results
Expression of transgenic CD28 and B7-2 rescues
development of DP thymocytes in the absence of pre-
TCR
We previously reported that during conventional thymic
development, CD28-B7 interactions prior to pre-TCR expression
are limited and that expression of both CD28 and B7-2 as
transgenes (CD28/B7) beginning early in DN cells substantially
altered thymic development, bypassing the requirement for pre-
TCR at the b checkpoint [7]. In wild-type B6 mice undergoing
pre-TCR-dependent development, the DN3 to DN4 transition is
rate limiting as cells rearrange and test for functional TCRb; this
developmental check point is reflected by a DN3 to DN4 ratio of
3.2+/20.3 (n=28). In contrast, in CD28/B7/B6 thymocytes the
DN3 to DN4 ratio is substantially reduced (0.2+/20.02, n=15).
In addition, expression of CD28/B7 transgenes on a CD3eKO
background (CD28/B7/CD3eKO) reversed the developmental
arrest observed in pre-TCR deficient CD3eKO mice and allowed
the efficient generation of DP cells (Figure 1A) [8,9]. The DN3 to
DN4 ratio in CD28/B7/CD3eKO thymocytes (0.2+/20.03,
n=9) is similar to that for CD28/B7/B6. The reversal of the
DN3 to DN4 ratios observed in mice expressing transgenic CD28/
B7 suggests that early CD28 signaling both replaces the
requirement for pre-TCR function and accelerates development
through the b checkpoint.
Further support for an accelerated development phenotype in
the CD28/B7/B6 mice derives from experiments in which short-
term labeling with BrdU was used to compare cell cycle regulation
in DN3 cells undergoing pre-TCR-dependent or CD28/B7-
dependent development (Figure 1B). In WT B6 mice only a low
proportion of early DN3 (CD25
high) cells were BrdU
+ and the
percentage of BrdU
+ cells substantially increased in late DN3
(CD25
low) cells following pre-TCR expression. Compared to WT
B6 mice, there were 2.5-fold more BrdU
+ DN3 cells in pre-TCR
deficient CD28/B7/CD3eKO mice. Importantly, this increase in
BrdU incorporation in CD28/B7/CD3eKO DN3 cells was
entirely due to the 3–4-fold higher proportion of BrdU
+ cells in
Figure 1. Analysis of thymic development and BrdU incorporation in mice undergoing pre-TCR-dependent or CD28/B7-dependent
development. (A) Thymocytes from B6, CD28/B7/B6, CD3eKO, and CD28/B7/CD3eKO mice were analyzed for CD4-CD8 subsets (CD4-PE and CD8-
Al594) or for lineage negative DN subsets (CD25-PE and CD44-APC). Thymus numbers are to the right of these figures. Staining profiles are
representative of .40 mice of each genotype analyzed. (B) Thymi were harvested from mice injected with BrdU, lineage negative cells were gated on
the indicated DN subsets, and analyzed for BrdU incorporation. These histograms show the percentage BrdU
+ cells present in all DN3 cells, early DN3
(CD25
hi) cells, or late DN3 (CD25
low) cells from B6 or CD28/B7/CD3eKO mice. This experiment is representative of three independent experiments
performed.
doi:10.1371/journal.pone.0020639.g001
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development accelerates the onset of proliferation in DN3 cells,
such that a significant proportion of early DN3 cell are
proliferating, prior to the stage at which completion of TCRb
rearrangement and acquisition of pre-TCR occurs in normal WT
B6 mice.
Pre-TCR-independent differentiation inhibits TCRb
rearrangement in DN thymocytes
Expression of TCRb protein occurs only after successful D-Jb
and V-DJb rearrangement are completed [19]. Following TCRb
protein expression and pre-TCR formation, a series of differen-
tiation events is initiated, and a critical component of this
differentiation program is the suppression of additional V-DJb
rearrangement [6]. Since CD28/B7 interactions in early DN cells
can induce differentiation in the absence of pre-TCR expression,
we examined the effects of this differentiation program on TCRb
rearrangement and allelic exclusion. We began by analyzing
TCRb rearrangement in purified DN cells isolated from either
pre-TCR deficient CD3eKO mice or from CD28/B7/CD3eKO
mice. As previously reported [20], the absence of CD3e precludes
pre-TCR expression, and CD3eKO thymocytes, although arrest-
ed at the early DN3 stage of development, undergo extensive D-Jb
and V-DJb rearrangement (Figure 2A). As compared to CD3eKO
mice, Db2–Jb2 rearrangement is substantially inhibited in all DN
cells or in DN2/3 and DN4 subsets from CD28/B7/CD3eKO
mice (Figure 2A). Further, analysis of Vb5-, Vb8-, and Vb14.1-
DJb2 rearrangements in these same DN thymocytes reveal that V-
DJb rearrangement is undetectable in CD28/B7/CD3eKO DN
cells (Figure 2 B–D). Thus, in the absence of pre-TCR expression
the differentiation program induced by CD28/B7 expression in
immature DN thymocytes results in at least a 10-fold inhibition of
both Db2–Jb2 and V–DJb2 rearrangement in DN cells.
Pre-TCR-independent development permits TCRa and
D-Jb but not V-DJb rearrangement in DP thymocytes
During conventional thymic development, only DN cells that
successfully rearrange TCRb and express a pre-TCR can
differentiate to DP cells and rearrange TCRa [3,21]. We asked
if CD28/B7-driven development would support TCRa rearrange-
ment in DP cells that were generated from DN cells which failed to
rearrange TCRb and lack pre-TCR signaling. Despite the
substantial inhibition of TCRb rearrangement observed in DN
cells from CD28/B7/CD3eKO mice (Figure 2), Va-Ja rearrange-
ment in DP cells from these same mice was not inhibited and, in
fact, appeared comparable to that detected in DP cells isolated
from WT B6 mice (Figure 3). This result demonstrates that CD28/
B7-driven development is not universally inhibitory to TCR
rearrangement and that efficient TCRa rearrangement in DP cells
can occur in the absence of expressed TCRb or pre-TCR
signaling.
Since the recombination machinery necessary for TCRa
rearrangement was intact in DP cells from CD28/B7/CD3eKO
mice, we reexamined TCRb rearrangement in these DP cells. In
fact, Db2-Jb2 rearrangement in DP cells from CD28/B7/
CD3eKO mice was equivalent to that measured in pre-TCR-
dependent DP cells from WT B6 mice (Figure 4A). However, in
marked contrast, both Vb5- and Vb8-DJb2 rearrangements were
substantially inhibited in these same DP cells (Figure 4B–C). Since
Db2- J b2 rearrangement is deficient in DN thymocytes from
CD28/B7/CD3eKO mice (Figure 2), this result demonstrates that
during CD28/B7-induced development, D-Jb2 rearrangement is
delayed but occurs efficiently in DP cells. Importantly, however,
even when D-Jb rearrangement is successful, the developmental
window in which V-DJb rearrangement can occur is highly
restricted. Suppression of V-DJb rearrangement does not require
pre-TCR expression but rather is developmentally enforced when
DN cells exit DN3 and mature to DN4 and DP cells.
Figure 2. CD28/B7-driven development inhibits TCRb rear-
rangement in DN thymocytes. 100, 30, and 10 ng of DNA was
analyzed by PCR to detect (A) Db2-Jb2 rearrangement, (B) Vb5-DJb2
rearrangement, (C) Vb8.1-DJb2 rearrangement, or (D) Vbb14.1-DJb2
rearrangement. (E) 10, 3, and 1 ng of DNA was analyzed by PCR to
detect unrearranged IgM as a loading control. The arrow in panel A
denotes the amplification of germline or non-rearranged Db2-Jb2 PCR
products. These results presented here comparing VDJb rearrange-
ments in CD3e and CD28/B7/CD3eKO DN cells were analyzed in the
same experiment and are representative of three experiments analyzing
DNA prepared from a total of six CD3eKO and CD28/B7/CD3eKO mice.
doi:10.1371/journal.pone.0020639.g002
Figure 3. TCRa rearrangement is equivalent in DP cells
generated via pre-TCR- or CD28/B7-dependent development.
300, 100, and 30 ng of DNA prepared from FCM sorted DP cells was
analyzed by PCR to detect the indicated Va-Ja rearrangements. The PCR
reaction for unrearranged IgM was performed using 10 ng DNA. The
results presented here comparing TCRa rearrangements in B6 and
CD28/B7/CD3eKO DP cells were analyzed in the same experiment and
are representative of three experiments performed using DNA prepared
from five to six B6 or CD28/B7/CD3eKO mice.
doi:10.1371/journal.pone.0020639.g003
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in DN but not DP cells
We next addressed the mechanism(s) that mediate suppression
of V-DJb rearrangement in the absence of pre-TCR. During
conventional pre-TCR dependent development, availability of
RAG proteins and accessibility of the TCRb locus to recombina-
tion machinery play essential roles in regulating V(D)J recombi-
nation. Thus, pre-TCR expression correlates with the onset of
extensive proliferation and other developmental changes that
include inhibition of RAG expression and changes in TCRb locus
accessibility, both of which enforce allelic suppression [22–25].
However, it is unclear whether pre-TCR expression is absolutely
required to induce these changes in RAG expression and locus
accessibility or if developmental events unlinked to pre-TCR
expression can also regulate these components. We therefore
undertook a series of experiments designed to measure RAG2
transcription and TCRb locus accessibility in DN and DP cells
undergoing pre-TCR-dependent or CD28/B7-driven pre-TCR-
independent development.
To study RAG2 expression we bred mice expressing both CD28
and B7-2 transgenes to a RAG2 transcriptional reporter mouse
(RAG2-GFP) [26] and analyzed GFP expression in littermates that
were RAG-GFP
+ and either negative (WT) or positive for CD28/
B7 transgenes (CD28/B7) (Figure 5A and B). In WT thymocytes
undergoing pre-TCR dependent development, peak GFP expres-
sion is detected in DN3 cells, the stage in which TCRb is actively
recombining, and decreases as cells express a pre-TCR and
differentiate to DN4 cells. GFP expression increases again as
thymocytes differentiate to DP cells where TCRa undergoes
recombination. Notably, GFP expression in DN3 and DN4 cells
from CD28/B7 mice is substantially lower than that observed in
comparable DN cells from WT littermates. Since TCRb
rearrangement normally begins in early DN3 cells, we evaluated
GFP expression in the early and late DN3 subsets. As compared to
GFP expression in early DN3 cells from WT littermates, GFP
expression is significantly reduced beginning in early DN3 cells
from CD28/B7 mice. GFP expression is comparably high in DP
cells from both WT and CD28/B7 mice. These results
demonstrate that the differentiation program induced by prema-
ture CD28/B7 expression inhibits RAG2 transcription beginning
in early DN3 cells and that this inhibition continues throughout
DN development. In contrast, CD28/B7-driven development does
not prevent RAG2 re-expression in DP cells.
Similar results were obtained when real-time PCR was used to
directly quantify RAG2 mRNA expression in sorted DN2/3,
DN4, and DP cells isolated from either pre-TCR-dependent B6
and pre-TCR-deficient CD28/B7/CD3eKO mice (Figure 5C). In
B6 DN thymocytes RAG2 expression peaks in DN2/3 cells and
decreases in proliferating DN4 cells. As compared to RAG2
expression in DN2/3 cells from B6 mice, DN2/3 cells from
CD28/B7/CD3eKO mice express approximately 50% less
RAG2, and RAG2 expression is reduced further in DN4 cells.
High expression of RAG2 is detected in DP cells from both B6 and
CD28/B7/CD3eKO mice.
Thus, analysis of RAG2 by these two different experimental
approachesrevealssimilarpatternsofRAG2expressionand suggests
that the accelerated developmental program initiated by CD28
signaling limits availability of RAG2 protein beginning in early DN3
cells. These results also demonstrate that the down regulation of
RAG2 transcription that occurs as cells transit from DN3 to DN4
and the re-expression of RAG2 in DP cells are developmentally
linked and do not require expression of a pre-TCR.
CD28-driven pre-TCR-independent development
selectively suppresses H3K4 tri-methylation of
unrearranged Vb genes
We next asked if, in addition to suppressing RAG2 expression,
development in the absence of pre-TCR expression also induces
epigenetic modifications in the TCRb locus that may inhibit
accessibility of the locus to recombination or transcription
machinery [27]. Tri-methylation of histone 3 at lysine 4
(H3K4Me3) is a physical modification that has been associated
with RAG recruitment to accessible antigen receptor loci [28–30].
We used ChIP coupled to real-time PCR to compare H3K4Me3
across the entire unrearranged TCRb locus in DN cells isolated
from either RAG2KO mice or from CD28/B7/RAG2KO mice
(Figure 6A) [7]. In DN cells from both RAG2KO and CD28/B7/
RAG2KO mice, levels of H3K4Me3 were equivalently high in Db
and Jb regions. In contrast, analysis of Vb loci indicated that
H3K4Me3 modification of Vb5 and Vb11, but not Vb2 regions
was suppressed in CD28/B7/RAG2KO relative to RAG2KO DN
cells. By this criterion the Db and Jb but not Vb regions of the
TCRb locus are available for recombination in CD28/B7 DN
cells. These observations suggest that in addition to inhibition of
RAG2 expression, impaired accessibility of Vb gene segments also
contributes to the inhibition of V-DJb recombination in these
developing DN cells.
CD28/B7-driven or pre-TCR-driven development
selectively suppresses germline transcription of
unrearranged Vb genes
We next assayed transcription of the unrearranged or germline
TCRb locus as a functional measure of chromatin accessibility
Figure 4. CD28/B7-dependent development permits Db2-Jb2
rearrangement but substantially inhibits V-DJb2 rearrange-
ment in DP thymocytes. 100, 30, and 10 ng of DNA prepared from
FCM sorted DP cells was analyzed by PCR to detect (A) Db2-Jb2
rearrangements, (B) Vb5-DJb2, or (C) Vb8.1-DJb2 rearrangements. The
PCR for unrearranged IgM, the loading control, was performed using 10,
3, and 1 ng of DNA (D). The results shown are representative of three
experiments performed using DNA prepared from five to six B6 or
CD28/B7/CD3eKO mice.
doi:10.1371/journal.pone.0020639.g004
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is a well established in vivo model that mimics pre-TCR signaling
and promotes the development of DP cells [18,20,32]. Analysis of
TCRb germline transcription in DN cells isolated from RAG2KO
mice after injection with either PBS or CD3e-specific mAb
(Figure 6B) revealed that transcription of Db and Jb regions was
equivalently high in both treated and control groups. In contrast,
after CD3e mAb injection, germline transcription of Vb genes,
with the exception of the 39 Vb14, was substantially inhibited. The
Vb14 gene is unusual in that it is the only mouse Vb gene located
39 of the Db and Jb regions, and it also has a transcriptional
orientation that is opposite to that of the other Vb genes. The
selective inhibition of 59Vb, but not Db or Jb, transcription
reported here is similar to results previously published [20,32].
These results suggest that pre-TCR-driven development enforces
b suppression in DN cells by selectively inhibiting the accessibility
of the 59 Vb locus to recombination machinery.
We next asked if the selective inhibition of Vb germline
transcription observed in this CD3e-induced model of pre-TCR-
driven development is unique or if inhibition of Vb germline
transcription also occurs if development is induced by transgenic
CD28/B7 in the absence of pre-TCR expression (Figure 6C).
Similar to the results described above for CD3e-induced
differentiation, Db and Jb regions from RAG2KO DN cells and
from CD28/B7/RAG2KO DN and DP cells expressed equivalent
and high levels of germline transcription. Further, as compared to
the robust transcription of the Db and Jb regions, transcription of
59 Vb genes was selectively and substantially inhibited in both DN
and DP cells from CD28/B7/RAG2KO mice. Thus, the selective
inhibition of 59Vb but not Db or Jb transcription also occurs in
DN and DP cells that develop in the absence of pre-TCR
expression. These results suggest that CD28/B7-driven develop-
ment also enforces V-DJb suppression in DN and DP cells by
selectively inhibiting the accessibility of the 59 Vb locus to
recombination machinery.
Discussion
In the present study, we have used an experimental model of
murine thymic development which disassociates the development
of DP cells from the requirement for pre-TCR expression in order
to identify requirements for TCRb rearrangement and allelic
exclusion. In this model, expression of transgenic CD28 and B7-2
beginning in early DN3 cells supports the efficient differentiation
of DP thymocytes in the absence of pre-TCR expression [7]. This
model reveals that pre-TCR expression is not required to enforce
b suppression at the level of V-DJb rearrangement or to allow
TCRa rearrangement in DP cells. However, this differentiation
pathway that occurs in the absence of a requirement for pre-TCR
expression never allows productive TCRb rearrangement to
occur. Failure to rearrange D-Jb in RAG-sufficient CD28/B7
DN cells (Figure 2A) is primarily the consequence of premature
RAG2 suppression beginning in early DN3 cells since Db and Jb
regions remain accessible in both DN and DP cells. Consistent
Figure 5. CD28/B7-dependent development suppresses RAG2 expression in DN but not DP cells. (A) Histograms show GFP
+ (RAG2)
staining on the FCM gated cell populations from WT GFP
+ (solid line) or CD28/B7 GFP
+ (dashed line) mice. Gates used to identify early and late DN3
subsets are as described in Figure 1B. The grey filled histograms show FL1 staining of the indicated DP and DN subsets analyzed from GFP
2 mice. (B)
This graph depicts the median channel number of GFP+ cells shown in panel (A) and is representative of three experiments performed. (C) This graph
summarizes real-time PCR quantification of RAG2 expression in FCM-sorted DN2/3, DN4 and DP cells from B6 and CD28/B7/CD3eKO thymi. RNA was
prepared and cDNA was synthesized as described in Materials and Methods. RAG2 cDNA was amplified using SABiosciences RT
2qPCR primers. RAG2
expression was normalized against b-actin expression. Real-time analysis was performed on three independent cDNA samples for each genotype.
Data are expressed as mean fold increase 6 SE relative to B6 DN2/3 cells.
doi:10.1371/journal.pone.0020639.g005
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when RAG is re-expressed and is no longer limiting (Figure 4A). In
addition to suppressing RAG2 transcription in DN cells, the
developmental program induced by transgenic CD28/B7 expres-
sion in the absence of a requirement for pre-TCR also inhibits V-
DJb rearrangement in DN and DP cells by a second RAG-
independent mechanism that results from the selective reduction
in locus accessibility of the 59 Vb region (Figure 6). These results
suggest that thymocyte development unlinked from a requirement
for pre-TCR expression can nevertheless enforce b suppression
not only by limiting RAG2 availability but also by selectively
inhibiting the accessibility of the 59 Vb locus to recombination
machinery.
These findings support a novel model for pre-TCR function in
thymic development and V-DJb recombination (Figure 7). During
conventional pre-TCR-dependent differentiation TCRb is rear-
ranged in early DN3 cells, so that proliferation and concomitant
down-regulation of both RAG expression and 59 Vb locus
accessibility do not occur until after productive TCRb rearrange-
ment is complete and pre-TCR is expressed in late DN3 cells.
Thus, early DN3 represents a developmental stage that is uniquely
permissive for TCRb rearrangement because of both high level
RAG expression and TCRb locus accessibility. If proliferation and
differentiation are initiated in early DN3 cells prior to successful
V-DJb rearrangement, cells exit this uniquely permissive devel-
opmental stage and are not able to complete V-DJb rearrange-
ment during any subsequent differentiation stage. In contrast, the
requirement for pre-TCR signaling to initiate differentiation of
DN3 cells enforces an essential ‘‘pause’’ at this developmental
stage which is uniquely permissive for V-DJb rearrangement. This
model emphasizes not only the importance of a pause at the DN3
stage that is permissive for TCRb rearrangement, but also the
necessity of preventing expression of other signaling molecules,
such as CD28, which are capable of accelerating DN to DP
differentiation, or of otherwise mimicking the effects of pre-TCR
signaling, prior to V-DJb rearrangement. The findings presented
here are similar to previous reports demonstrating that transgenic
TCR expression promotes development to DP cells and suppresses
endogenous V-DJb rearrangement [32–36]. The suppression of
endogenous TCRb rearrangement by TCR transgene in these
systems may be mediated either by accelerating normal DN
differentiation and/or by mimicking more specific pre-TCR
signals that are required to enforce V-DJb suppression.
During normal pre-TCR dependent development, TCRa
rearrangement occurs subsequent to TCRb rearrangement and
pre-TCR signaling [3,21]. We demonstrate that in CD28/B7/
CD3eKO mice, TCRa rearrangement occurs efficiently in DP
cells that are generated without rearranged TCRb or pre-TCR
expression. Expression of activated Lck [33,37] or b-catenin [36]
transgenes has previously been reported to bypass the b
checkpoint and to rearrange TCRa in the absence of productive
V-DJb rearrangement. These results are consistent with results
presented here and support a model in which TCRa rearrange-
ment is developmentally regulated and independent of TCRb
rearrangement or unique pre-TCR signals.
During conventional thymic development high expression of
RAG proteins is restricted to developmental stages in which
TCRb or TCRa rearrangement occurs [22–24]. While the signals
that initiate RAG expression are not fully understood, it is known
that levels of RAG proteins in developing cells are negatively
regulated by proliferation, with both RAG2 transcription and
protein stability inhibited in cycling cells [38–40]. In the present
study, we report that CD28-driven differentiation accelerates the
onset of proliferation in early DN3 cells and concomitantly
suppresses RAG2 transcription beginning in early DN3 cells. Since
it was reported that the cyclinA/CDK2-mediated phosphorylation
of RAG2 in proliferating cells efficiently targets RAG2 for
ubiquitin-mediated degradation [40], itis likelythat the accelerated
onset of proliferation induced by CD28 in DN cells targets RAG2
for degradation and limits RAG2 protein availability beginning in
early DN3cells when it is essential for TCRb rearrangement. When
Figure 6. Accessibility of DJb and Vb regions are differentially
regulated during thymic development. (A) Fold-enrichment
H3K4Me3 analyzed by ChIP for Vb (2, 5, and 11) Db1, and Jb (1.1 and
2.7) regions. Each data point represents the mean 6 SEM of six
independent lysates prepared from RAG2KO (black bar) or CD28/B7/
RAG2KO (grey bar) DN cells. H3K4Me3 of b-actin was used as a
normalization control. (B) Relative germline transcription of the
unrearranged TCRb region in RAG2KO DN cells from mice previously
injected with either PBS (dark brick bar) or CD3e mAb (open brick bar).
These results represent the mean 6 SEM of three to five mice per group
analyzed in two separate experiments. (C) Relative germline transcrip-
tion of the unrearranged TCRb region in RAG2KO DN cells (black bar),
CD28/B7/RAG2KO DN cells (grey bar) or CD28/B7/RAG2KO DP cells
(black striped bar). These results represent the mean 6 SEM of five to
six mice per genotype analyzed in two separate experiments. For both
(B) and (C) data shown are normalized to transcription measured in
RAG2KO DN cells using b-actin transcription as a loading control for
each group. For (A), (B), and (C) the order of the data points reflects the
59–39 genomic organization of the TCRb region and brackets identify
comparisons that are significantly different (p,0.05): * indicates
p#0.03, ** indicates p#0.02, and *** indicates p#0.001.
doi:10.1371/journal.pone.0020639.g006
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proteinsaredegradedonlyafterproductiveTCRbrearrangementis
completed and pre-TCR is expressed. Thus, inhibition of RAG
subsequent to pre-TCR expression prevents any additional V-DJb
rearrangement in DN cells and enforces b suppression. In contrast,
if premature differentiation of DN cells is induced by alternative
pathways, such as that mediated by CD28/B7, RAG expression is
prematurely inhibited and productive TCRb rearrangement can
never occur, resulting in a sterile pathway that lacks TCRb
expression.
It is widely recognized that regulated RAG expression is not
sufficient to completely explain the restricted patterns of V(D)J
recombination [25,38,40] that are reported. The ‘‘accessibility
hypothesis’’ first proposed by Alt and colleagues [27], states that
V(D)J recombination is controlled by developmental and tissue-
restricted chromatin modifications that differentially regulate
accessibility of the TCR or Ig genes to recombination machinery.
Selective suppression of Vb region accessibility has been invoked
to explain the fact that allelic expression is maintained in DP cells,
where RAG is expressed and TCRa rearrangement occurs but V-
DJb rearrangement does not [6]. Previous reports, as well as the
study presented here, have shown that selective suppression of Vb
but not Db or Jb accessibility occurs when DN to DP development
is induced by TCR transgenes [41] or CD3e mAb injection [32].
However, it was not clear from these earlier studies whether down-
regulation of Vb region accessibility required expression of a pre-
TCR. The observation that DP cells generated by transgenic
CD28/B7 are permissive for V-Ja and D-Jb rearrangement, but
not for V-DJb rearrangement suggests that developmental down-
regulation of Vb region accessibility in DP cells can occur
independent of pre-TCR expression. To directly assess TCRb
accessibility, we first measured H3K4Me3 histone tri-methylation,
a modification reported to be associated with actively transcribing
genes and to bind to the RAG2 PHD domain [28–30,42]. In the
absence of pre-TCR expression, CD28-driven differentiation
suppressed H3K4Me3 in some unrearranged Vb loci, but not in
Db or Jb regions, suggesting that developmentally determined
inhibition of 59 Vb region accessibility is a second independent
mechanism mediating the suppression of V-DJb rearrangement in
developing DN cells. Germline transcription of non-rearranged
TCR loci provides a functional measure of accessibility to
transcriptional machinery, and has been widely identified as a
prerequisite for rearrangement of T and B cell receptors [31].
Germline transcription of Db and Jb loci was found to be
equivalent in DN thymocytes from RAG2KO and CD28/B7/
RAG2KO mice. In striking contrast, germline transcription of 59
Vb loci was markedly suppressed in DN thymocytes from RAG-
deficient mice expressing CD28 and B7 transgenes. Germline
transcription of TCRb loci in DP cells induced by CD28 signals
was similar to that detected in DN cells: suppressed transcription
of 59Vb loci and robust transcription of Db and Jb loci. These
results demonstrate that, in contrast to Db and Jb region
accessibility, 59 Vb region accessibility is strictly confined to the
DN3 stage of differentiation and that subsequent down-regulation
of Vb accessibility is not dependent on pre-TCR expression but
rather is differentiation-induced.
The studies reported here demonstrate that the pre-TCR is not
unique in its ability to drive thymocyte differentiation and to
suppress V-DJb rearrangement. A CD28-driven pre-TCR-inde-
pendent pathway of development is sufficient to support
differentiation while suppressing TCRb rearrangement through
effects on RAG2 expression and TCR Vb locus accessibility. The
requirement for pre-TCR expression to initiate differentiation,
and the exclusion of alternative signaling molecules like CD28,
ensure that development and suppression of V-DJb rearrangement
occurs only after productive TCRb is complete.
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Figure 7. Model: The requirement for pre-TCR signaling enforces an essential pause in DN cell development.
doi:10.1371/journal.pone.0020639.g007
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